← ANALYSTS · TIPRANKS
Eva Fortea Verdejo · Wells Fargo
Hits
80%
60 of 75 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+54.1%
Over a year after the rating, TipRanks’ measure
Our companies rated now
9
Buy / hold / sell: 6 / 3 / 0
Upside of the analyst’s targets
+45.1%
Average over 9 current targets, to the last price
The market’s answer to the ratings
−0.6%
Day-0 move against SPY in the rating’s direction, average over 3 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Aug 27on TipRanks 07:15 | RVMDRevolution Medicines · $41.5B | Assigned | Buy | $240 | +34.9% | +2.0%next day −5.8% · 5 days −4.9% | ↗ |
| Aug 25on TipRanks Aug 26 05:10 | ZYMEIWMZymeworks · $1.8B | Assigned | Buy | $40.00 | +59.8% | −4.8%next day +6.7% · 5 days +8.5% | ↗ |
| Aug 14on TipRanks 06:55 | CELCIWMCelcuity · $2.9B | Reiterated | Buy | $166 | +193.4% | +6.4%next day +1.0% · 5 days +3.0% | ↗ |
| Aug 12on TipRanks 06:55 | BCAXIWMBicara Therapeutics Inc. · $1.2B | Assigned | Hold | $16.00 → $23.00+43.8% | +37.1% | +3.4%next day −4.8% · 5 days +5.4% | ↗ |
| Aug 6on TipRanks 07:10 | EXELExelixis · $14.8B | Assigned | Hold | $49.00 → $50.00+2.0% | −19.7% | −7.8%next day +3.0% · 5 days −4.3% | ↗ |
| Aug 6on TipRanks 06:10 | RCUSIWMArcus Biosciences · $2.9B | Assigned | Hold | $23.00 → $26.00+13.0% | +17.5% | +2.4%next day +0.4% · 5 days +0.7% | ↗ |
| Aug 5on TipRanks 07:45 | IDYAIWMIDEAYA Biosciences · $3.3B | Reiterated | Buy | $48.00 | +46.1% | 0.0%next day +0.7% · 5 days +2.2% | ↗ |
| Jun 29on TipRanks Jun 30 05:10 | GMABGenmab · $22.3B | Assigned | Buy | $40.00 | +8.1% | −2.0%next day +4.8% · 5 days +11.2% | ↗ |
| May 19on TipRanks May 20 05:30 | RLAYIWMRelay Therapeutics · $3.8B | Reiterated | Buy | $21.00 | +29.0% | +0.4%next day +6.8% · 5 days +17.3% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗